Carolyn Schultz-Walter is a seasoned clinical research professional, currently serving as the Director of Project Delivery at PPD, where she leverages over 20 years of extensive experience in both Sponsor and Contract Research Organizations (CROs). In her pivotal role, Carolyn is responsible for overseeing the...
Carolyn Schultz-Walter is a seasoned clinical research professional, currently serving as the Director of Project Delivery at PPD, where she leverages over 20 years of extensive experience in both Sponsor and Contract Research Organizations (CROs). In her pivotal role, Carolyn is responsible for overseeing the strategic execution of clinical trials across various therapeutic areas, including Women’s Health, Cardiology, Urology, Infectious Disease, CNS, and Immunology. Her deep expertise in clinical operations is complemented by her proficiency in regulatory submissions and adherence to GCP and ICH-GCP guidelines, ensuring that all projects meet the highest standards of compliance and quality.
At PPD, Carolyn leads key projects that focus on optimizing clinical trial processes and enhancing operational efficiencies. She is particularly adept at issue management, utilizing her comprehensive knowledge of Clinical Trial Management Systems (CTMS) to identify potential challenges early and implement effective solutions. Her experience spans all study phases, allowing her to mentor and guide her team through complex project landscapes while fostering a collaborative environment that encourages innovation and professional growth.
As a demonstrated team leader and mentor, Carolyn is committed to developing talent within her organization. She actively engages in training initiatives, sharing her insights on best practices in clinical monitoring and project management. Her leadership style not only inspires her colleagues but also contributes to the successful delivery of high-quality clinical trials, ultimately advancing the field of pharmaceuticals and improving patient outcomes. Carolyn’s multifaceted expertise and dedication to excellence make her a key asset to PPD and the broader clinical research community.
